154 related articles for article (PubMed ID: 12547232)
21. [Nervous system manifestation in aceruloplasminemia].
Miyajima H
Nihon Naika Gakkai Zasshi; 2004 Aug; 93(8):1579-84. PubMed ID: 15384686
[No Abstract] [Full Text] [Related]
22. Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia.
Zanardi A; Conti A; Cremonesi M; D'Adamo P; Gilberti E; Apostoli P; Cannistraci CV; Piperno A; David S; Alessio M
EMBO Mol Med; 2018 Jan; 10(1):91-106. PubMed ID: 29183916
[TBL] [Abstract][Full Text] [Related]
23. Glial fibrillary acidic protein is greatly modified by oxidative stress in aceruloplasminemia brain.
Kaneko K; Nakamura A; Yoshida K; Kametani F; Higuchi K; Ikeda S
Free Radic Res; 2002 Mar; 36(3):303-6. PubMed ID: 12071349
[TBL] [Abstract][Full Text] [Related]
24. MR imaging of cerebral cortical involvement in aceruloplasminemia.
Grisoli M; Piperno A; Chiapparini L; Mariani R; Savoiardo M
AJNR Am J Neuroradiol; 2005 Mar; 26(3):657-61. PubMed ID: 15760883
[TBL] [Abstract][Full Text] [Related]
25. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis.
Xu X; Pin S; Gathinji M; Fuchs R; Harris ZL
Ann N Y Acad Sci; 2004 Mar; 1012():299-305. PubMed ID: 15105274
[TBL] [Abstract][Full Text] [Related]
26. Astrocytic deformity and globular structures are characteristic of the brains of patients with aceruloplasminemia.
Kaneko K; Yoshida K; Arima K; Ohara S; Miyajima H; Kato T; Ohta M; Ikeda SI
J Neuropathol Exp Neurol; 2002 Dec; 61(12):1069-77. PubMed ID: 12484569
[TBL] [Abstract][Full Text] [Related]
27. Deferasirox Might Be Effective for Microcytic Anemia and Neurological Symptoms Associated with Aceruloplasminemia: A Case Report and Review of the Literature.
Miyake Z; Nakamagoe K; Yoshida K; Kondo T; Tamaoka A
Intern Med; 2020 Jul; 59(14):1755-1761. PubMed ID: 32238721
[TBL] [Abstract][Full Text] [Related]
28. Cerebellar ataxia associated with heteroallelic ceruloplasmin gene mutation.
Miyajima H; Kono S; Takahashi Y; Sugimoto M; Sakamoto M; Sakai N
Neurology; 2001 Dec; 57(12):2205-10. PubMed ID: 11756598
[TBL] [Abstract][Full Text] [Related]
29. Increased oxysterols associated with iron accumulation in the brains and visceral organs of acaeruloplasminaemia patients.
Miyajima H; Adachi J; Kohno S; Takahashi Y; Ueno Y; Naito T
QJM; 2001 Aug; 94(8):417-22. PubMed ID: 11493718
[TBL] [Abstract][Full Text] [Related]
30. Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury.
Patel BN; Dunn RJ; Jeong SY; Zhu Q; Julien JP; David S
J Neurosci; 2002 Aug; 22(15):6578-86. PubMed ID: 12151537
[TBL] [Abstract][Full Text] [Related]
31. Hepatic iron overload associated with a decreased serum ceruloplasmin level in a novel clinical type of aceruloplasminemia.
Kono S; Suzuki H; Takahashi K; Takahashi Y; Shirakawa K; Murakawa Y; Yamaguchi S; Miyajima H
Gastroenterology; 2006 Jul; 131(1):240-5. PubMed ID: 16831606
[TBL] [Abstract][Full Text] [Related]
32. Treatment of symptomatic heterozygous aceruloplasminemia with oral zinc sulphate.
Kuhn J; Bewermeyer H; Miyajima H; Takahashi Y; Kuhn KF; Hoogenraad TU
Brain Dev; 2007 Aug; 29(7):450-3. PubMed ID: 17307325
[TBL] [Abstract][Full Text] [Related]
33. Hereditary ceruloplasmin deficiency with hemosiderosis.
Okamoto N; Wada S; Oga T; Kawabata Y; Baba Y; Habu D; Takeda Z; Wada Y
Hum Genet; 1996 Jun; 97(6):755-8. PubMed ID: 8641692
[TBL] [Abstract][Full Text] [Related]
34. Aceruloplasminemia with Abnormal Compound Heterozygous Mutations Developed Neurological Dysfunction during Phlebotomy Therapy.
Watanabe M; Ohyama K; Suzuki M; Nosaki Y; Hara T; Iwai K; Kono S; Miyajima H; Mokuno K
Intern Med; 2018 Sep; 57(18):2713-2718. PubMed ID: 29709961
[TBL] [Abstract][Full Text] [Related]
35. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism.
Harris ZL; Takahashi Y; Miyajima H; Serizawa M; MacGillivray RT; Gitlin JD
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2539-43. PubMed ID: 7708681
[TBL] [Abstract][Full Text] [Related]
36. Coexistence of Copper in the Iron-Rich Particles of Aceruloplasminemia Brain.
Yoshida K; Hayashi H; Wakusawa S; Shigemasa R; Koide R; Ishikawa T; Tatsumi Y; Kato K; Ohara S; Ikeda SI
Biol Trace Elem Res; 2017 Jan; 175(1):79-86. PubMed ID: 27272717
[TBL] [Abstract][Full Text] [Related]
37. Aceruloplasminemia.
Gitlin JD
Pediatr Res; 1998 Sep; 44(3):271-6. PubMed ID: 9727700
[TBL] [Abstract][Full Text] [Related]
38. Increased vulnerability to rotenone-induced neurotoxicity in ceruloplasmin-deficient mice.
Kaneko K; Hineno A; Yoshida K; Ikeda S
Neurosci Lett; 2008 Nov; 446(1):56-8. PubMed ID: 18804145
[TBL] [Abstract][Full Text] [Related]
39. MR imaging for the quantitative assessment of brain iron in aceruloplasminemia: A postmortem validation study.
Vroegindeweij LHP; Wielopolski PA; Boon AJW; Wilson JHP; Verdijk RM; Zheng S; Bonnet S; Bossoni L; van der Weerd L; Hernandez-Tamames JA; Langendonk JG
Neuroimage; 2021 Dec; 245():118752. PubMed ID: 34823024
[TBL] [Abstract][Full Text] [Related]
40. Teaching NeuroImages: neurodegeneration with brain iron accumulation in aceruloplasminemia.
Parks NE; Vandorpe RA; Moeller JJ
Neurology; 2013 Nov; 81(20):e151-2. PubMed ID: 24218322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
